磁共振成像可视化多发性硬化柔脑膜炎症
本综述评估磁共振成像在显示多发性硬化患者柔脑膜强化中的作用与前景。组织病理学研究显示皮质脑膜表面存在炎性浸润,部分伴B细胞富集的三级淋巴滤泡特征。高分辨率钆增强扫描可检出柔脑膜强化,其多见于进展型多发性硬化,并与皮质下软膜病变及皮质萎缩相关。
要点
- 高分辨率钆增强MRI可检出多发性硬化患者的柔脑膜强化。
- 柔脑膜强化多见于进展型多发性硬化,与软膜皮质病变和皮质萎缩相关。
- 柔脑膜强化可能作为进展型多发性硬化病理的替代标志物。
核心结论
- 越来越多的证据提示灰质脱髓鞘、皮质萎缩和柔脑膜炎症可能是进展型多发性硬化病理的重要组成部分,并提供了新的治疗靶点。
- 柔脑膜强化可能成为此类病理的有用替代标志物,或许有助于理解进展型多发性硬化的自然史,但其对治疗开发和临床护理的最终影响仍需进一步研究。
研究设计与样本
- 本文为综述,评估磁共振成像在显示多发性硬化患者柔脑膜强化中的当前地位与未来前景。
主要发现
- 多发性硬化患者病程早期即可出现皮质萎缩和软膜表面脱髓鞘,并在进展期加速。
- 患者组织病理学研究显示沿皮质脑膜表面存在炎性浸润,部分病例具有B细胞富集的三级淋巴滤泡特征。
- 近期磁共振成像数据表明,高分辨率钆增强对比扫描可通过柔脑膜强化的存在检出此类炎症。
- 临床与磁共振成像相关性研究提示,柔脑膜强化在进展型多发性硬化患者中最常见,并与软膜皮质病变和皮质萎缩相关。
临床怎么用
- 对多发性硬化患者可关注高分辨率钆增强扫描显示的柔脑膜强化,作为进展型病理的影像线索。
- 柔脑膜强化与软膜皮质病变和皮质萎缩相关,解读影像时宜结合皮质病变评估。
- 将其用于治疗开发与临床决策尚需进一步研究,暂不宜作为常规决策依据。
局限性
- 柔脑膜强化对治疗开发和临床护理的最终影响仍需进一步研究。
- 对皮质病变发病机制的理解仍不完整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system traditionally characterized by an initial relapsing-remitting clinical course and focal inflammatory lesions that have a predilection for the periventricular white matter. Recently, however, histopathologic and imaging studies have illustrated a more complex pathologic substrate involving cortical demyelination, gray matter atrophy, and meningeal inflammation. Neuroimaging advances have facilitated improved detection of cortical pathology, but our understanding of the pathogenesis of cortical disease remains incomplete. The purpose of this review is to evaluate the current status and future prospects regarding the emerging role of magnetic resonance imaging to visualize leptomeningeal enhancement in patients with MS and place these findings in the proper pathobiologic and clinical context. OBSERVATIONS: Cortical atrophy and demyelination along the subpial surface appear early in the disease course in patients with MS but accelerate in progressive stages. Histopathologic studies of patients have shown the presence of inflammatory infiltrates, in some cases with features of B cell-rich tertiary lymph follicles, along the cortical meningeal surface. Recent magnetic resonance imaging data demonstrate the ability to detect such inflammation using high-resolution gadolinium-enhanced contrast scans by the presence of leptomeningeal enhancement. Clinical and magnetic resonance imaging correlation studies indicate that leptomeningeal enhancement is most common in patients with progressive forms of MS and shows a relationship to subpial cortical lesions and cortical atrophy. CONCLUSIONS AND RELEVANCE: A growing body of evidence suggests that gray matter demyelination, cortical atrophy, and leptomeningeal inflammation may be important components of progressive MS pathology and provide a new therapeutic target. Leptomeningeal enhancement may prove a useful surrogate marker for such pathology, perhaps improving our understanding of the natural history of progressive MS, although its ultimate effect on therapeutic development and clinical care requires further study.
引用
- Zurawski J, Lassmann H, Bakshi R, et al. Use of Magnetic Resonance Imaging to Visualize Leptomeningeal Inflammation in Patients With Multiple Sclerosis: A Review. JAMA Neurol. 2017. PMID: 27893883. doi:10.1001/jamaneurol.2016.4237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。